“…Crucially, mutation of S215 to alanine, an amino acid refractory to phosphorylation (a so-called 'phospho mutant'), abolishes ERG function in prostate cancer cells (Selvaraj et al, 2015). Although several studies have implicated ERG as a mediator of EC survival, proliferation, motility and vascular integrity (Birdsey et al, 2008(Birdsey et al, , 2012(Birdsey et al, , 2015Liu and Patient, 2008;Yuan et al, 2011), whether ERG acts as a hub, integrating signals downstream of VEGF to control these diverse EC behaviors is not known.…”